Amphastar Pharmaceuticals, Inc. (AMPH)

27.69 +0.14 (+0.51%) USD  |  NASDAQ  |  Feb 24, 14:42
More

Amphastar Pharmaceuticals Sell Recommendations

Sell Recommendations Chart

View Sell Recommendations for AMPH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Sell Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Sell Recommendations Range, Past 5 Years

View Sell Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Sell Recommendations Benchmarks

View Sell Recommendations Benchmarks
Start Trial
Eli Lilly & Co. Upgrade
Pfizer Inc. Upgrade
Organon & Co. Upgrade
Catalyst Pharmaceuticals, Inc. Upgrade
CorMedix, Inc. Upgrade